Immediate Impact

59 standout
Sub-graph 1 of 21

Citing Papers

Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
2024 Standout
1 intermediate paper

Works of C. Paris being referenced

Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis
2014

Author Peers

Author Last Decade Papers Cites
C. Paris 250 3 13 205 180 5 359
B De La Fuente 237 2 30 183 162 5 319
M. Caropreso 204 3 11 140 124 8 318
Liudmyla Kononenko 215 14 151 123 6 315
Olja Stevanović 216 47 227 85 7 402
Ivana Gmizić 209 44 214 84 6 378
Antonio Sircana 117 2 33 183 101 8 388
Aleksandra Radovanović Spurnić 208 36 214 84 11 391
S. N. Leikhter 240 1 32 211 89 3 388
S Ferolla 265 9 126 144 10 362
Martina Goffredo 180 1 13 190 144 6 387

All Works

Loading papers...

Rankless by CCL
2026